|
Monday April 14, 2003
at
15.00 Central European Time
14.00 London Time
9.00 New York Time
Please call: +31 20 531 58 71
15 minutes prior to commencement and state that you are calling for
Crucell's Q1 Results
The conference call will be available via an audio webcast on the Investor Information section of www.crucell.com. The webcast will be available afterwards for replay at the website.
The conference call will be recorded and replay is available until
April 21, 2003
Dial-in number: +31 70 315 43 00
Code replay: 298 700
About Crucell N.V. (Euronext Amsterdam: CRXL, NASDAQ: CRXL)
Crucell N.V. discovers and develops biopharmaceuticals that use the human immune system to combat infectious diseases and other conditions. Crucell leverages its patented technologies, PER.C6(TM), AdVac(TM), and MAbstract(TM), for discovery, development and production of antibodies and vaccines. Crucell offers its technologies to the pharmaceutical and biotechnology industry and also uses them to create its own product pipeline. Crucell is headquartered in Leiden, The Netherlands ( www.crucell.com.)
PLEASE RETURN FAX BEFORE APRIL 9 2003 TO
Tim van der Zanden- Hill and Knowlton
Tel : +31-20-4044707, Fax : +31-20-6449736
...... Yes, I would like to participate in the Crucell conference call
...... No, I will not be able to participate in the Crucell conference call but would like to receive the materials of the presentation
...... I am not interested in Crucell at this time
Name :............. Company.............
Phone...........Fax number:....................
E-mail address :.................
invitation
| 
